Context.-Although myomas shrink after menopause, the cellular mechanism for
this phenomenon has received little attention. It was recently demonstrate
d that fibrous degeneration is significantly associated with postmenopausal
status in both small and large myomas.
Objective.-The purpose of the present study was to evaluate whether reducti
on in myoma cell size is also associated with postmenopausal status in smal
l myomas.
Design.-Tumor size and patient age have also been related to fibrous degene
ration in small (<1 cm) myomas. Therefore, in the present study, 10 pairs o
f premenopausal and postmenopausal small myomas were matched within 3 years
for patient age, within 1 mm for size, and within 1 grade for degree of fi
brous degeneration. Most of the women were in their 50s, the decade during
which postmenopausal fibrous degeneration in small myomas is most prevalent
. Myoma cell size was derived by morphometric evaluation of relative myoma
cell area (correcting for percentage of stroma, as measured by point counti
ng) and by direct counting of the number of myoma cells per unit area in tr
ichrome-stained sections.
Results.-Small myomas from postmenopausal women had significantly (P < .05)
smaller cell sizes than did size-matched myomas from age-matched premenopa
usal women. Myoma cell sizes and nucleus-cell (N/C) ratios were highly vari
able, especially in premenopausal myomas.
Conclusions.-Reduction in myoma cell size is significantly associated with
postmenopausal status in small uterine leiomyomas and may be an important m
echanism for postmenopausal shrinkage of myomas. In addition, the high vari
ability of myoma cell size and N/C ratio may further support the somatic mu
tation theory (ie, the theory that diverse mutations may account not only f
or variations in the growth potential of uterine myomas, but also for varia
tions in their cellular details).